Literature DB >> 8147099

Comparison of influenza serological techniques by international collaborative study.

J M Wood1, R E Gaines-Das, J Taylor, P Chakraverty.   

Abstract

An international collaborative study was performed to investigate the reproducibility of influenza serological techniques. Participants in seven laboratories representing five countries measured antibody to A/Sichuan/2/87 (H3N2), A/Taiwan/1/86 (H1N1) and B/Beijing/1/87 influenza viruses in 11 human sera and three postinfection ferret sera. Two different serological techniques were used, haemagglutination inhibition (HI) and single-radial haemolysis (SRH) and, although each technique was reproducible within laboratories, variability between laboratories was higher for HI (maximum variability 32-fold; geometric coefficient of variation, GCV, 112%) than for SRH (maximum variability 3.8-fold; GCV 57%). The use of a standard serum allowed direct comparison of HI and SRH data and, for each technique, a standard serum improved inter-laboratory agreement. For influenza A viruses there was a correlation between HI and SRH antibodies (correlation coefficient approximately 0.9). An HI titre of 1:40 in human sera corresponded to an SRH titre of 19-33 mm2. The results of the study indicate that two sera would be expected to contain different antibody levels if their HI titres differed by > fourfold and SRH areas differed by > 50%. Both SRH and HI possessed equivalent sensitivity for measurement of antibody to influenza A viruses but SRH was more sensitive for detection of antibody to influenza B viruses. The study provided valuable information about standardization of antibody assays.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8147099     DOI: 10.1016/0264-410x(94)90056-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  56 in total

1.  Survey on influenza laboratory diagnostic and surveillance methods in Europe. European Scientific Working Group on Influenza.

Authors:  C Hannoun; B Tumova
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

Authors:  Laurent Coudeville; Philippe Andre; Fabrice Bailleux; Françoise Weber; Stanley Plotkin
Journal:  Hum Vaccin       Date:  2010-10-01

3.  Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories.

Authors:  Mary Zacour; Brian J Ward; Angela Brewer; Patrick Tang; Guy Boivin; Yan Li; Michelle Warhuus; Shelly A McNeil; Jason J LeBlanc; Todd F Hatchette
Journal:  Clin Vaccine Immunol       Date:  2016-01-27

4.  Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire.

Authors:  A G Elder; B O'Donnell; E A McCruden; I S Symington; W F Carman
Journal:  BMJ       Date:  1996-11-16

5.  Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.

Authors:  Shahzma Merani; George A Kuchel; Alison Kleppinger; Janet E McElhaney
Journal:  Exp Gerontol       Date:  2017-09-27       Impact factor: 4.032

6.  Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.

Authors:  David A Nace; Chyongchiou Jeng Lin; Ted M Ross; Stacey Saracco; Roberta M Churilla; Richard K Zimmerman
Journal:  J Infect Dis       Date:  2014-12-17       Impact factor: 5.226

7.  Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive population.

Authors:  Li Yu; Mark T Esser; Judith Falloon; Tonya Villafana; Harry Yang
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

8.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

9.  Reproducibility of serologic assays for influenza virus A (H5N1).

Authors:  Iain Stephenson; Alan Heath; Diane Major; Robert W Newman; Katja Hoschler; Wang Junzi; Jacqueline M Katz; Jerry P Weir; Maria C Zambon; John M Wood
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.

Authors:  Pierre Van Damme; Robert Arnou; Froukje Kafeja; Anne Fiquet; Patrick Richard; Stéphane Thomas; Gilles Meghlaoui; Sandrine Isabelle Samson; Emilio Ledesma
Journal:  BMC Infect Dis       Date:  2010-05-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.